- Home
- PBT vs TERN Comparison
PBT vs TERN Comparison
Compare PBT & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBT
- TERN
- Stock Information
- Founded
- PBT 1980
- TERN 2017
- Country
- PBT United States
- TERN United States
- Employees
- PBT N/A
- TERN N/A
- Industry
- PBT Oil & Gas Production
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- PBT Energy
- TERN Health Care
- Exchange
- PBT Nasdaq
- TERN Nasdaq
- Market Cap
- PBT 564.4M
- TERN 586.0M
- IPO Year
- PBT N/A
- TERN 2021
- Fundamental
- Price
- PBT $12.87
- TERN $6.17
- Analyst Decision
- PBT
- TERN Buy
- Analyst Count
- PBT 0
- TERN 6
- Target Price
- PBT N/A
- TERN $16.42
- AVG Volume (30 Days)
- PBT 133.7K
- TERN 1.3M
- Earning Date
- PBT 01-01-0001
- TERN 11-12-2024
- Dividend Yield
- PBT 5.94%
- TERN N/A
- EPS Growth
- PBT N/A
- TERN N/A
- EPS
- PBT N/A
- TERN N/A
- Revenue
- PBT $37,735,284.00
- TERN N/A
- Revenue This Year
- PBT N/A
- TERN N/A
- Revenue Next Year
- PBT N/A
- TERN N/A
- P/E Ratio
- PBT $16.53
- TERN N/A
- Revenue Growth
- PBT 25.46
- TERN N/A
- 52 Week Low
- PBT $10.14
- TERN $3.59
- 52 Week High
- PBT $19.74
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- PBT 69.08
- TERN 31.82
- Support Level
- PBT $10.41
- TERN $6.99
- Resistance Level
- PBT $12.76
- TERN $7.53
- Average True Range (ATR)
- PBT 0.47
- TERN 0.47
- MACD
- PBT 0.21
- TERN -0.02
- Stochastic Oscillator
- PBT 91.11
- TERN 16.57
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.